GARVAN INSTITUTE OF MEDICAL RESEARCH IMAGE: HISTOPATHOLOGICAL IMAGE OF A HIGH GRADE PROSTATE CANCER. CREDIT: PROF JAMES KENCH New epigenetic biomarkers to predict more aggressive forms of prostate cancer have been discovered by scientists at the Garvan Institute of Medical Research. The biomarkers can be used in combination with traditional clinical tools to predict if...
LUND UNIVERSITY A new study by researchers at Lund University in Sweden supports the notion that patients with type 2 diabetes patient should be divided into subgroups and given individualised treatment. The study demonstrates that there are distinct epigenetic differences between different groups of patients with type 2 diabetes. The epigenetic markers are also associated...
